MGLL and posterior cortical atrophy: In 2011, Nomura and coworkers showed that MAGL is increased in androgen-independent human PCa cell lines, and that pharmacological or genetic inhibition of MAGL impairs PCa aggressiveness. Furthermore, MAGL was found as part of an EMT and stem-like gene signature, suggesting MAGL as a potential therapeutic target in advanced PCa (127).